Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) EBIT Margin (2017 - 2019)

Historic EBIT Margin for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2019 value amounting to 55313.51%.

  • Iterum Therapeutics' EBIT Margin fell 489245100.0% to 55313.51% in Q1 2019 from the same period last year, while for Dec 2019 it was 275732.43%, marking a year-over-year decrease of 2669225400.0%. This contributed to the annual value of 564.66% for FY2024, which is 9422600.0% down from last year.
  • Latest data reveals that Iterum Therapeutics reported EBIT Margin of 55313.51% as of Q1 2019, which was down 489245100.0% from 10017.99% recorded in Q4 2018.
  • In the past 5 years, Iterum Therapeutics' EBIT Margin ranged from a high of 2637.25% in Q4 2017 and a low of 55313.51% during Q1 2019
  • In the last 3 years, Iterum Therapeutics' EBIT Margin had a median value of 8338.38% in 2018 and averaged 13964.39%.
  • Per our database at Business Quant, Iterum Therapeutics' EBIT Margin plummeted by -46194000bps in 2018 and then crashed by -489245100bps in 2019.
  • Quarter analysis of 3 years shows Iterum Therapeutics' EBIT Margin stood at 2637.25% in 2017, then plummeted by -280bps to 10017.99% in 2018, then plummeted by -452bps to 55313.51% in 2019.
  • Its last three reported values are 55313.51% in Q1 2019, 10017.99% for Q4 2018, and 9837.01% during Q3 2018.